Literature DB >> 25753100

Prostate cancer: 2-year ADT improves survival in patients receiving high-dose radiotherapy.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25753100     DOI： 10.1038/nrurol.2015.43

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.

Authors:  Almudena Zapatero; Araceli Guerrero; Xavier Maldonado; Ana Alvarez; Carmen Gonzalez San Segundo; Maria Angeles Cabeza Rodríguez; Victor Macias; Agustí Pedro Olive; Francesc Casas; Ana Boladeras; Carmen Martín de Vidales; Maria Luisa Vazquez de la Torre; Salvador Villà; Aitor Perez de la Haza; Felipe A Calvo
Journal:  Lancet Oncol       Date:  2015-02-19       Impact factor: 41.316
  1 in total
  1 in total

Review 1.  Role of prostate cancer stem-like cells in the development of antiandrogen resistance.

Authors:  Prem Prakash Kushwaha; Shiv Verma; Shashank Kumar; Sanjay Gupta
Journal:  Cancer Drug Resist       Date:  2022-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.